{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T15:11:40Z","timestamp":1767453100805,"version":"3.40.3"},"publisher-location":"Cham","reference-count":75,"publisher":"Springer International Publishing","isbn-type":[{"type":"print","value":"9783030561529"},{"type":"electronic","value":"9783030561536"}],"license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021]]},"DOI":"10.1007\/978-3-030-56153-6_20","type":"book-chapter","created":{"date-parts":[[2021,7,31]],"date-time":"2021-07-31T08:02:37Z","timestamp":1627718557000},"page":"345-362","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Curcumin for the Treatment of Prostate Diseases: A Systematic Review of Controlled Clinical Trials"],"prefix":"10.1007","author":[{"given":"Mohammad","family":"Bagherniya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gholamreza","family":"Askari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Babak","family":"Alikiaii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saeed","family":"Abbasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davood","family":"Soleimani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thozhukat","family":"Sathyapalan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tannaz","family":"Jamialahmadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amirhossein","family":"Sahebkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,8,1]]},"reference":[{"issue":"10","key":"20_CR1","doi-asserted-by":"publisher","first-page":"e0139440","DOI":"10.1371\/journal.pone.0139440","volume":"10","author":"HI Scher","year":"2015","unstructured":"Scher HI, Solo K, Valant J, Todd MB, Mehra M (2015) Prevalence of prostate cancer clinical states and mortality in the United States: estimates using a dynamic progression model. PLoS One 10(10):e0139440. https:\/\/doi.org\/10.1371\/journal.pone.0139440","journal-title":"PLoS One"},{"key":"20_CR2","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.mgene.2014.07.007","volume":"2","author":"S Jain","year":"2014","unstructured":"Jain S, Saxena S, Kumar A (2014) Epidemiology of prostate cancer in India. Meta Gene 2:596\u2013605","journal-title":"Meta Gene"},{"issue":"3","key":"20_CR3","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.ucl.2016.04.001","volume":"43","author":"KB Egan","year":"2016","unstructured":"Egan KB (2016) The epidemiology of benign prostatic hyperplasia associated with lower urinary tract symptoms: prevalence and incident rates. Urol Clin North Am 43(3):289\u2013297","journal-title":"Urol Clin North Am"},{"issue":"4","key":"20_CR4","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.maturitas.2012.04.014","volume":"72","author":"D Ilic","year":"2012","unstructured":"Ilic D, Misso M (2012) Lycopene for the prevention and treatment of benign prostatic hyperplasia and prostate cancer: a systematic review. Maturitas 72(4):269\u2013276","journal-title":"Maturitas"},{"issue":"22","key":"20_CR5","doi-asserted-by":"publisher","first-page":"9575","DOI":"10.7314\/APJCP.2014.15.22.9575","volume":"15","author":"M Daniyal","year":"2014","unstructured":"Daniyal M, Siddiqui ZA, Akram M, Asif H, Sultana S, Khan A (2014) Epidemiology, etiology, diagnosis and treatment of prostate cancer. Asian Pac J Cancer Prev 15(22):9575\u20139578","journal-title":"Asian Pac J Cancer Prev"},{"issue":"3","key":"20_CR6","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.ajur.2017.06.004","volume":"4","author":"KB Lim","year":"2017","unstructured":"Lim KB (2017) Epidemiology of clinical benign prostatic hyperplasia. Asian J Urol 4(3):148\u2013151","journal-title":"Asian J Urol"},{"issue":"13","key":"20_CR7","doi-asserted-by":"publisher","first-page":"5137","DOI":"10.7314\/APJCP.2015.16.13.5137","volume":"16","author":"MN Bashir","year":"2015","unstructured":"Bashir MN (2015) Epidemiology of prostate cancer. Asian Pac J Cancer Prev 16(13):5137\u20135141","journal-title":"Asian Pac J Cancer Prev"},{"issue":"5","key":"20_CR8","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/j.eururo.2012.11.013","volume":"6","author":"EH Allott","year":"2013","unstructured":"Allott EH, Masko EM, Freedland SJ (2013) Obesity and prostate cancer: weighing the evidence. Eur Urol 6(5):800\u2013809","journal-title":"Eur Urol"},{"key":"20_CR9","doi-asserted-by":"publisher","unstructured":"Tacklind J, Fink HA, MacDonald R, Rutks I, Wilt TJ (2010) Finasteride for benign prostatic hyperplasia. Cochrane Database Syst Rev (10):CD006015. https:\/\/doi.org\/10.1002\/14651858.CD006015.pub3","DOI":"10.1002\/14651858.CD006015.pub3"},{"key":"20_CR10","doi-asserted-by":"publisher","unstructured":"Hoffman RM, MacDonald R, Wilt T (2000) Laser prostatectomy for benign prostatic obstruction. Cochrane Database Syst Rev (1):CD001987. https:\/\/doi.org\/10.1002\/14651858.CD001987.pub2","DOI":"10.1002\/14651858.CD001987.pub2"},{"issue":"4","key":"20_CR11","doi-asserted-by":"publisher","first-page":"196","DOI":"10.3322\/CA.2008.0002","volume":"58","author":"MD Michaelson","year":"2008","unstructured":"Michaelson MD, Cotter SE, Gargollo PC, Zietman AL, Dahl DM, Smith MR (2008) Management of complications of prostate cancer treatment. CA Cancer J Clin 58(4):196\u2013213","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"20_CR12","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s11764-013-0312-8","volume":"8","author":"M Darwish-Yassine","year":"2014","unstructured":"Darwish-Yassine M, Berenji M, Wing D, Copeland G, Demers RY, Garlinghouse C et al (2014) Evaluating long-term patient-centered outcomes following prostate cancer treatment: findings from the Michigan Prostate Cancer Survivor study. J Cancer Surviv 8(1):121\u2013130","journal-title":"J Cancer Surviv"},{"key":"20_CR13","doi-asserted-by":"publisher","unstructured":"Bagherniya M, Johnston TP, Sahebkar A (2020) Regulation of apolipoprotein B by natural products and nutraceuticals: a comprehensive review. Curr Med Chem. https:\/\/doi.org\/10.2174\/0929867327666200427092114. Online ahead of print","DOI":"10.2174\/0929867327666200427092114"},{"key":"20_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12944-020-01250-6","volume":"19","author":"S Talebi","year":"2020","unstructured":"Talebi S, Bagherniya M, Atkin SL, Askari G, Orafai HM, Sahebkar A (2020) The beneficial effects of nutraceuticals and natural products on small dense LDL levels, LDL particle number and LDL particle size: a clinical review. Lipids Health Dis 19:1\u201321","journal-title":"Lipids Health Dis"},{"issue":"13","key":"20_CR15","doi-asserted-by":"publisher","first-page":"2889","DOI":"10.1080\/10408398.2015.1077195","volume":"57","author":"B Kocaadam","year":"2017","unstructured":"Kocaadam B, \u015eanlier N (2017) Curcumin, an active component of turmeric (Curcuma longa), and its effects on health. Crit Rev Food Sci Nutr 57(13):2889\u20132895","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"2","key":"20_CR16","doi-asserted-by":"publisher","first-page":"131","DOI":"10.2174\/1567205053585882","volume":"2","author":"JM Ringman","year":"2005","unstructured":"Ringman JM, Frautschy SA, Cole GM, Masterman DL, Cummings JL (2005) A potential role of the curry spice curcumin in Alzheimer\u2019s disease. Curr Alzheimer Res 2(2):131\u2013136","journal-title":"Curr Alzheimer Res"},{"issue":"2","key":"20_CR17","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.ijcard.2009.01.073","volume":"133","author":"W Wongcharoen","year":"2009","unstructured":"Wongcharoen W, Phrommintikul A (2009) The protective role of curcumin in cardiovascular diseases. Int J Cardiol 133(2):145\u2013151","journal-title":"Int J Cardiol"},{"issue":"3-4","key":"20_CR18","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.phymed.2009.05.020","volume":"17","author":"M Iranshahi","year":"2010","unstructured":"Iranshahi M, Sahebkar A, Hosseini ST, Takasaki M, Konoshima T, Tokuda H (2010) Cancer chemopreventive activity of diversin from Ferula diversivittata in vitro and in vivo. Phytomedicine 17(3-4):269\u2013273","journal-title":"Phytomedicine"},{"key":"20_CR19","doi-asserted-by":"crossref","unstructured":"Soleimani V, Sahebkar A, Hosseinzadeh H (2018) Turmeric (Curcuma longa) and its major constituent (curcumin) as nontoxic and safe substances: Review. Phytother Res 32(6):985\u2013995. https:\/\/doi.org\/10.1002\/ptr.6054. Epub 2018 Feb 26. PMID: 29480523","DOI":"10.1002\/ptr.6054"},{"key":"20_CR20","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.phrs.2017.12.020","volume":"130","author":"M Bagherniya","year":"2018","unstructured":"Bagherniya M, Nobili V, Blesso CN, Sahebkar A (2018) Medicinal plants and bioactive natural compounds in the treatment of non-alcoholic fatty liver disease: a clinical review. Pharmacol Res 130:213\u2013240","journal-title":"Pharmacol Res"},{"key":"20_CR21","doi-asserted-by":"publisher","first-page":"186864","DOI":"10.1155\/2014\/186864","volume":"2014","author":"S Zorofchian Moghadamtousi","year":"2014","unstructured":"Zorofchian Moghadamtousi S, Abdul Kadir H, Hassandarvish P, Tajik H, Abubakar S, Zandi K (2014) A review on antibacterial, antiviral, and antifungal activity of curcumin. Biomed Res Int 2014:186864. https:\/\/doi.org\/10.1155\/2014\/186864","journal-title":"Biomed Res Int"},{"issue":"1","key":"20_CR22","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1080\/10408398.2017.1358139","volume":"59","author":"H Mollazadeh","year":"2019","unstructured":"Mollazadeh H, Cicero AFG, Blesso CN, Pirro M, Majeed M, Sahebkar A (2019) Immune modulation by curcumin: The role of interleukin-10. Crit Rev Food Sci Nutr 59(1):89\u2013101","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"4","key":"20_CR23","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s40291-016-0202-7","volume":"20","author":"AA Momtazi","year":"2016","unstructured":"Momtazi AA, Derosa G, Maffioli P, Banach M, Sahebkar A (2016) Role of microRNAs in the therapeutic effects of curcumin in non-cancer diseases. Mol Diagn Ther 20(4):335\u2013345","journal-title":"Mol Diagn Ther"},{"key":"20_CR24","doi-asserted-by":"crossref","unstructured":"Hasanzadeh S, Read MI, Bland AR, Majeed M, Jamialahmadi T, Sahebkar A (2020) Curcumin: an inflammasome silencer. Pharmacol Res 159:104921. https:\/\/doi.org\/10.1016\/j.phrs.2020.104921. Epub 2020 May 25. PMID: 32464325","DOI":"10.1016\/j.phrs.2020.104921"},{"issue":"5","key":"20_CR25","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1002\/med.20188","volume":"30","author":"DK Agrawal","year":"2010","unstructured":"Agrawal DK, Mishra PK (2010) Curcumin and its analogues: potential anticancer agents. Med Res Rev 30(5):818\u2013860","journal-title":"Med Res Rev"},{"issue":"1\/A","key":"20_CR26","first-page":"363","volume":"23","author":"BB Aggarwal","year":"2003","unstructured":"Aggarwal BB, Kumar A, Bharti AC (2003) Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res 23(1\/A):363\u2013398","journal-title":"Anticancer Res"},{"issue":"28","key":"20_CR27","doi-asserted-by":"publisher","first-page":"4386","DOI":"10.2174\/1381612822666160527113501","volume":"22","author":"AA Momtazi","year":"2016","unstructured":"Momtazi AA, Sahebkar A (2016) Difluorinated curcumin: A promising curcumin analogue with improved anti-tumor activity and pharmacokinetic profile. Curr Pharm Des 22(28):4386\u20134397. https:\/\/doi.org\/10.2174\/1381612822666160527113501","journal-title":"Curr Pharm Des"},{"key":"20_CR28","doi-asserted-by":"crossref","unstructured":"Teymouri M, Pirro M, Johnston TP, Sahebkar A (2017) Curcumin as a multifaceted compound against human papilloma virus infection and cervical cancers: A review of chemistry, cellular, molecular, and preclinical features. BioFactors 43(3):331\u2013346","DOI":"10.1002\/biof.1344"},{"key":"20_CR29","doi-asserted-by":"crossref","unstructured":"Mohajeri M, Bianconi V, \u00c1vila-Rodriguez MF, Barreto GE, Jamialahmadi T, Pirro M, Sahebkar A (2020) Curcumin: a phytochemical modulator of estrogens and androgens in tumors of the reproductive system. Pharmacol Res 156:104765. https:\/\/doi.org\/10.1016\/j.phrs.2020.104765. Epub 2020 Mar 23. PMID: 32217147","DOI":"10.1016\/j.phrs.2020.104765"},{"issue":"8","key":"20_CR30","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1038\/sj.onc.1207284","volume":"23","author":"D Chendil","year":"2004","unstructured":"Chendil D, Ranga RS, Meigooni D, Sathishkumar S, Ahmed MM (2004) Curcumin confers radiosensitizing effect in prostate cancer cell line PC-3. Oncogene 23(8):1599\u20131607","journal-title":"Oncogene"},{"issue":"52","key":"20_CR31","doi-asserted-by":"publisher","first-page":"7597","DOI":"10.1038\/sj.onc.1204997","volume":"20","author":"A Mukhopadhyay","year":"2001","unstructured":"Mukhopadhyay A, Bueso-Ramos C, Chatterjee D, Pantazis P, Aggarwal BB (2001) Curcumin downregulates cell survival mechanisms in human prostate cancer cell lines. Oncogene 20(52):7597\u20137609","journal-title":"Oncogene"},{"issue":"4","key":"20_CR32","first-page":"825","volume":"21","author":"K Nakamura","year":"2002","unstructured":"Nakamura K, Yasunaga Y, Segawa T, Ko D, Moul JW, Srivastava S et al (2002) Curcumin down-regulates AR gene expression and activation in prostate cancer cell lines. Int J Oncol 21(4):825\u2013830","journal-title":"Int J Oncol"},{"key":"20_CR33","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/978-0-387-46401-5_3","volume-title":"The molecular targets and therapeutic uses of curcumin in health and disease","author":"VP Menon","year":"2007","unstructured":"Menon VP, Sudheer AR (2007) Antioxidant and anti-inflammatory properties of curcumin. In: Aggarwal BB, Surh YJ, Shishodia S (eds) The molecular targets and therapeutic uses of curcumin in health and disease. Springer, Boston, MA, pp 105\u2013125. ISBN-13: 9780387464008"},{"issue":"1 Suppl 4","key":"20_CR34","first-page":"17","volume":"54","author":"A Ledda","year":"2012","unstructured":"Ledda A, Belcaro G, Dugall M, Luzzi R, Scoccianti M, Togni S et al (2012) Meriva(R), a lecithinized curcumin delivery system, in the control of benign prostatic hyperplasia: a pilot, product evaluation registry study. Panminerva Med 54(1 Suppl 4):17\u201322","journal-title":"Panminerva Med"},{"issue":"7","key":"20_CR35","first-page":"1390","volume":"20","author":"V Cosentino","year":"2016","unstructured":"Cosentino V, Fratter A, Cosentino M (2016) Anti-inflammatory effects exerted by Killox\u00ae, an innovative formulation of food supplement with curcumin, in urology. Eur Rev Med Pharmacol Sci 20(7):1390\u20131398","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"4","key":"20_CR36","doi-asserted-by":"publisher","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","volume":"151","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 151(4):264\u2013269","journal-title":"Ann Intern Med"},{"issue":"1","key":"20_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","volume":"17","author":"AR Jadad","year":"1996","unstructured":"Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJM, Gavaghan DJ et al (1996) Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17(1):1\u201312","journal-title":"Control Clin Trials"},{"key":"20_CR38","doi-asserted-by":"crossref","unstructured":"Moher D, Cook D, Jadad A, Tugwell P, Moher M, Jones A et al (1999) Assessing the quality of reports of randomised trials: implications for the conduct of meta-analyses. Health Technol Assess 3(12):i\u2013iv., 1\u201398","DOI":"10.3310\/hta3120"},{"issue":"18","key":"20_CR39","first-page":"4196","volume":"21","author":"A Ledda","year":"2017","unstructured":"Ledda A, Belcaro G, Dugall M, Luzzi R, Hosoi M, Feragalli B et al (2017) A natural pharma standard supplement formulation to control treatment-related toxicity and oxidative stress in genitourinary cancer: a preliminary study. Eur Rev Med Pharmacol Sci 21(18):4196\u20134202","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"6","key":"20_CR40","first-page":"263","volume":"40","author":"T Noguchi","year":"2017","unstructured":"Noguchi T (2017) The effects of curcumin to the PSA recurrence of prostate cancer after surgical treatment. Teikyo Med J 40(6):263\u2013272","journal-title":"Teikyo Med J"},{"issue":"2","key":"20_CR41","doi-asserted-by":"publisher","first-page":"110","DOI":"10.4081\/aiua.2017.2.110","volume":"89","author":"G Morgia","year":"2017","unstructured":"Morgia G, Russo GI, Urzi D, Privitera S, Castelli T, Favilla V et al (2017) A phase II, randomized, single-blinded, placebo-controlled clinical trial on the efficacy of Curcumina and Calendula suppositories for the treatment of patients with chronic prostatitis\/ chronic pelvic pain syndrome type III. Arch Ital Urol Androl 89(2):110\u2013113","journal-title":"Arch Ital Urol Androl"},{"issue":"2","key":"20_CR42","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1002\/ptr.6230","volume":"33","author":"A Saadipoor","year":"2019","unstructured":"Saadipoor A, Razzaghdoust A, Simforoosh N, Mahdavi A, Bakhshandeh M, Moghadam M et al (2019) Randomized, double-blind, placebo-controlled phase II trial of nanocurcumin in prostate cancer patients undergoing radiotherapy. Phytother Res 33(2):370\u2013378","journal-title":"Phytother Res"},{"issue":"1","key":"20_CR43","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1080\/01635581.2016.1115527","volume":"68","author":"J Hejazi","year":"2016","unstructured":"Hejazi J, Rastmanesh R, Taleban FA, Molana SH, Hejazi E, Ehtejab G et al (2016) Effect of curcumin supplementation during radiotherapy on oxidative status of patients with prostate cancer: a double blinded, randomized, placebo-controlled study. Nutr Cancer 68(1):77\u201385","journal-title":"Nutr Cancer"},{"issue":"10","key":"20_CR44","first-page":"320","volume":"5","author":"J Hejazi","year":"2013","unstructured":"Hejazi J, Rastmanesh R, Taleban FA, Molana SH, Ehtejab G (2013) A pilot clinical trial of radioprotective effects of curcumin supplementation in patients with prostate cancer. J Cancer Sci Ther 5(10):320\u2013324","journal-title":"J Cancer Sci Ther"},{"issue":"7","key":"20_CR45","first-page":"1390","volume":"20","author":"V Cosentino","year":"2016","unstructured":"Cosentino V, Fratter A, Cosentino M (2016) Anti-inflammatory effects exerted by Killox (R), an innovative formulation of food supplement with curcumin, in urology. Eur Rev Med Pharmacol Sci 20(7):1390\u20131398","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"7","key":"20_CR46","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1002\/pros.23317","volume":"77","author":"MD van Die","year":"2017","unstructured":"van Die MD, Williams SG, Emery J, Bone KM, Taylor JM, Lusk E et al (2017) A placebo-controlled double-blinded randomized pilot study of combination phytotherapy in biochemically recurrent prostate cancer. Prostate 77(7):765\u2013775","journal-title":"Prostate"},{"issue":"2","key":"20_CR47","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/pcan.2014.6","volume":"17","author":"R Thomas","year":"2014","unstructured":"Thomas R, Williams M, Sharma H, Chaudry A, Bellamy P (2014) A double-blind, placebo-controlled randomised trial evaluating the effect of a polyphenol-rich whole food supplement on PSA progression in men with prostate cancer-the UK NCRN Pomi-T study. Prostate Cancer Prostatic Dis 17(2):180\u2013186","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"6","key":"20_CR48","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1002\/pros.23766","volume":"79","author":"YH Choi","year":"2019","unstructured":"Choi YH, Han DH, Kim SW, Kim MJ, Sung HH, Jeon HG et al (2019) A randomized, double-blind, placebo-controlled trial to evaluate the role of curcumin in prostate cancer patients with intermittent androgen deprivation. Prostate 79(6):614\u2013621","journal-title":"Prostate"},{"issue":"1","key":"20_CR49","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.colsurfb.2010.03.039","volume":"79","author":"MM Yallapu","year":"2010","unstructured":"Yallapu MM, Jaggi M, Chauhan SC (2010) \u03b2-Cyclodextrin-curcumin self-assembly enhances curcumin delivery in prostate cancer cells. Colloids Surf B Biointerfaces 79(1):113\u2013125","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"3","key":"20_CR50","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1007\/s10549-009-0612-x","volume":"122","author":"M Kakarala","year":"2010","unstructured":"Kakarala M, Brenner DE, Korkaya H, Cheng C, Tazi K, Ginestier C et al (2010) Targeting breast stem cells with the cancer preventive compounds curcumin and piperine. Breast Cancer Res Treat 122(3):777\u2013785","journal-title":"Breast Cancer Res Treat"},{"issue":"20","key":"20_CR51","doi-asserted-by":"publisher","first-page":"7490","DOI":"10.1158\/1078-0432.CCR-05-1192","volume":"11","author":"BB Aggarwal","year":"2005","unstructured":"Aggarwal BB, Shishodia S, Takada Y, Banerjee S, Newman RA, Bueso-Ramos CE et al (2005) Curcumin suppresses the paclitaxel-induced nuclear factor-\u03baB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice. Clin Cancer Res 11(20):7490\u20137498","journal-title":"Clin Cancer Res"},{"key":"20_CR52","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.lfs.2016.03.036","volume":"152","author":"BC Jordan","year":"2016","unstructured":"Jordan BC, Mock CD, Thilagavathi R, Selvam C (2016) Molecular mechanisms of curcumin and its semisynthetic analogues in prostate cancer prevention and treatment. Life Sci 152:135\u2013144","journal-title":"Life Sci"},{"issue":"6","key":"20_CR53","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.3892\/ijo.2015.3202","volume":"47","author":"Y Du","year":"2015","unstructured":"Du Y, Long Q, Zhang L, Shi Y, Liu X, Li X et al (2015) Curcumin inhibits cancer-associated fibroblast-driven prostate cancer invasion through MAOA\/mTOR\/HIF-1\u03b1 signaling. Int J Oncol 47(6):2064\u20132072","journal-title":"Int J Oncol"},{"issue":"2","key":"20_CR54","doi-asserted-by":"publisher","first-page":"279","DOI":"10.3892\/ol.2012.710","volume":"4","author":"X Wei","year":"2012","unstructured":"Wei X, Du Z-Y, Cui X-X, Verano M, Mo RQ, Tang ZK et al (2012) Effects of cyclohexanone analogues of curcumin on growth, apoptosis and NF-\u03baB activity in PC-3 human prostate cancer cells. Oncol Lett 4(2):279\u2013284","journal-title":"Oncol Lett"},{"issue":"9","key":"20_CR55","doi-asserted-by":"publisher","first-page":"656","DOI":"10.4111\/kju.2015.56.9.656","volume":"56","author":"JH Hong","year":"2015","unstructured":"Hong JH, Lee G, Choi HY (2015) Effect of curcumin on the interaction between androgen receptor and Wnt\/\u03b2-catenin in LNCaP xenografts. Korean J Urol 56(9):656\u2013665","journal-title":"Korean J Urol"},{"issue":"1","key":"20_CR56","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s12263-009-0152-3","volume":"5","author":"M-H Teiten","year":"2010","unstructured":"Teiten M-H, Gaascht F, Eifes S, Dicato M, Diederich M (2010) Chemopreventive potential of curcumin in prostate cancer. Genes Nutr 5(1):61\u201374","journal-title":"Genes Nutr"},{"issue":"2 Suppl 3","key":"20_CR57","doi-asserted-by":"publisher","first-page":"S86","DOI":"10.1053\/j.seminoncol.2005.03.015","volume":"32","author":"MS Anscher","year":"2005","unstructured":"Anscher MS, Vujaskovic Z (2005) Mechanisms and potential targets for prevention and treatment of normal tissue injury after radiation therapy. Semin Oncol 32(2 Suppl 3):S86\u2013S91","journal-title":"Semin Oncol"},{"issue":"4","key":"20_CR58","first-page":"169","volume":"6","author":"X Huang","year":"2012","unstructured":"Huang X, Song C, Zhong C, Wang F (2012) Research progress in the radioprotective effect of superoxide dismutase. Drug Discov Ther 6(4):169\u2013177","journal-title":"Drug Discov Ther"},{"issue":"5","key":"20_CR59","doi-asserted-by":"publisher","first-page":"5728","DOI":"10.1002\/jcp.27442","volume":"234","author":"B Farhood","year":"2019","unstructured":"Farhood B, Mortezaee K, Goradel NH, Khanlarkhani N, Salehi E, Nashtaei MS et al (2019) Curcumin as an anti-inflammatory agent: Implications to radiotherapy and chemotherapy. J Cell Physiol 234(5):5728\u20135740","journal-title":"J Cell Physiol"},{"issue":"3","key":"20_CR60","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1177\/1534735407305655","volume":"6","author":"RW Moss","year":"2007","unstructured":"Moss RW (2007) Do antioxidants interfere with radiation therapy for cancer? Integr Cancer Ther 6(3):281\u2013292","journal-title":"Integr Cancer Ther"},{"issue":"1","key":"20_CR61","first-page":"22","volume":"13","author":"CB Simone II","year":"2007","unstructured":"Simone CB II, Simone NL, Simone V, Simone CB (2007) Antioxidants and other nutrients do not interfere with chemotherapy or radiation therapy and can increase kill and increase survival, Part 2. Altern Ther Health Med 13(1):22\u201329","journal-title":"Altern Ther Health Med"},{"issue":"2","key":"20_CR62","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1002\/jcp.25778","volume":"233","author":"E Abdollahi","year":"2018","unstructured":"Abdollahi E, Momtazi AA, Johnston TP, Sahebkar A (2018) Therapeutic effects of curcumin in inflammatory and immune-mediated diseases: a nature-made jack-of-all-trades? J Cell Physiol 233(2):830\u2013848","journal-title":"J Cell Physiol"},{"issue":"6","key":"20_CR63","doi-asserted-by":"publisher","first-page":"921","DOI":"10.2174\/1381612822666161006151605","volume":"23","author":"M Ghandadi","year":"2017","unstructured":"Ghandadi M, Sahebkar A (2017) Curcumin: An effective inhibitor of interleukin-6. Curr Pharm Des 23(6):921\u2013931","journal-title":"Curr Pharm Des"},{"issue":"1","key":"20_CR64","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1667\/RR3255.1","volume":"180","author":"JL Ryan","year":"2013","unstructured":"Ryan JL, Heckler CE, Ling M, Katz A, Williams JP, Pentland AP et al (2013) Curcumin for radiation dermatitis: a randomized, double-blind, placebo-controlled clinical trial of thirty breast cancer patients. Radiat Res 180(1):34\u201343","journal-title":"Radiat Res"},{"issue":"6","key":"20_CR65","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/s00204-008-0352-4","volume":"83","author":"M Akpolat","year":"2009","unstructured":"Akpolat M, Kanter M, Uzal MC (2009) Protective effects of curcumin against gamma radiation-induced ileal mucosal damage. Arch Toxicol 83(6):609\u2013617","journal-title":"Arch Toxicol"},{"issue":"3","key":"20_CR66","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/S0360-3016(02)02794-3","volume":"53","author":"H Inano","year":"2002","unstructured":"Inano H, Onoda M (2002) Radioprotective action of curcumin extracted from Curcuma longa LINN: inhibitory effect on formation of urinary 8-hydroxy-2\u2032-deoxyguanosine, tumorigenesis, but not mortality, induced by \u03b3-ray irradiation. Int J Radiat Oncol Biol Phys 53(3):735\u2013743","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"20_CR67","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.ucl.2007.09.012","volume":"35","author":"JC Nickel","year":"2008","unstructured":"Nickel JC (2008) Inflammation and benign prostatic hyperplasia. Urol Clin North Am 35(1):109\u2013115","journal-title":"Urol Clin North Am"},{"issue":"5","key":"20_CR68","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1016\/j.eururo.2006.12.011","volume":"51","author":"G Kramer","year":"2007","unstructured":"Kramer G, Mitteregger D, Marberger M (2007) Is benign prostatic hyperplasia (BPH) an immune inflammatory disease? Eur Urol 51(5):1202\u20131216","journal-title":"Eur Urol"},{"issue":"1","key":"20_CR69","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/j.1476-5381.2012.01969.x","volume":"167","author":"D Altavilla","year":"2012","unstructured":"Altavilla D, Minutoli L, Polito F, Irrera N, Arena S, Magno C et al (2012) Effects of flavocoxid, a dual inhibitor of COX and 5-lipoxygenase enzymes, on benign prostatic hyperplasia. Br J Pharmacol 167(1):95\u2013108","journal-title":"Br J Pharmacol"},{"issue":"6","key":"20_CR70","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s10565-012-9234-x","volume":"28","author":"M Notara","year":"2012","unstructured":"Notara M, Ahmed A (2012) Benign prostate hyperplasia and stem cells: a new therapeutic opportunity. Cell Biol Toxicol 28(6):435\u2013442","journal-title":"Cell Biol Toxicol"},{"issue":"2","key":"20_CR71","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.eururo.2006.07.016","volume":"51","author":"G Penna","year":"2007","unstructured":"Penna G, Mondaini N, Amuchastegui S, Degli Innocenti S, Carini M, Giubilei G et al (2007) Seminal plasma cytokines and chemokines in prostate inflammation: interleukin 8 as a predictive biomarker in chronic prostatitis\/chronic pelvic pain syndrome and benign prostatic hyperplasia. Eur Urol 51(2):524\u2013533","journal-title":"Eur Urol"},{"issue":"3","key":"20_CR72","first-page":"469","volume":"19","author":"JW Cho","year":"2007","unstructured":"Cho JW, Lee KS, Kim CW (2007) Curcumin attenuates the expression of IL-1\u03b2, IL-6, and TNF-\u03b1 as well as cyclin E in TNF-\u03b1-treated HaCaT cells; NF-\u03baB and MAPKs as potential upstream targets. Int J Mol Med 19(3):469\u2013474","journal-title":"Int J Mol Med"},{"issue":"2","key":"20_CR73","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1089\/ars.2008.2140","volume":"11","author":"SK Jain","year":"2009","unstructured":"Jain SK, Rains J, Croad J, Larson B, Jones K (2009) Curcumin supplementation lowers TNF-\u03b1, IL-6, IL-8, and MCP-1 secretion in high glucose-treated cultured monocytes and blood levels of TNF-\u03b1, IL-6, MCP-1, glucose, and glycosylated hemoglobin in diabetic rats. Antioxid Redox Signal 11(2):241\u2013249","journal-title":"Antioxid Redox Signal"},{"issue":"1","key":"20_CR74","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/advances\/nmx011","volume":"9","author":"AL Lopresti","year":"2018","unstructured":"Lopresti AL (2018) The problem of curcumin and its bioavailability: could its gastrointestinal influence contribute to its overall health-enhancing effects? Adv Nutr 9(1):41\u201350","journal-title":"Adv Nutr"},{"issue":"6","key":"20_CR75","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1021\/mp700113r","volume":"4","author":"P Anand","year":"2007","unstructured":"Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB (2007) Bioavailability of curcumin: problems and promises. Mol Pharm 4(6):807\u2013818","journal-title":"Mol Pharm"}],"container-title":["Advances in Experimental Medicine and Biology","Studies on Biomarkers and New Targets in Aging Research in Iran"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-030-56153-6_20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T10:44:42Z","timestamp":1725533082000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-030-56153-6_20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"ISBN":["9783030561529","9783030561536"],"references-count":75,"URL":"https:\/\/doi.org\/10.1007\/978-3-030-56153-6_20","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"type":"print","value":"0065-2598"},{"type":"electronic","value":"2214-8019"}],"subject":[],"published":{"date-parts":[[2021]]},"assertion":[{"value":"1 August 2021","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}